Dichlorvos (DDVP) Risk Characterization Document - California ...

Dichlorvos (DDVP) Risk Characterization Document - California ... Dichlorvos (DDVP) Risk Characterization Document - California ...

30.12.2013 Views

Table 12. Selected no-observed-effect levels (NOELs) and lowest-observed-effect levels (LOELs) of DDVP from reproductive toxicity studies. Plasma ChE a RBC ChE a Brain ChE a Other Effects Species Route Duration NOEL LOEL % C NOEL LOEL % C NOEL LOEL % C NOEL LOEL Effects Ref. b (mg/kg-day) (mg/kg-day) (mg/kg-day) (mg/kg-day) Rat water daily c (range finding) females and - 3 48-66% - 3 58-61% - 3 54-93% - 1 males F 0 females F 0 - - - - - - 11-17 22-44 maternal-reduced body weight gain, food consumption females F 0 - - - - - - 24 41 maternal- tremors (first on day 7) fetal F 1 - - - - - - 11 22 fetal-cholinergic signs Rat water daily c,d 2.7 9.5 parental 2* -decreased fertility, females F 0 1.1 4.6 45%

G. DEVELOPMENTAL TOXICITY Summary: DDVP, given by oral or inhalation routes, was not teratogenic in rats, mice, or rabbits. Cholinergic signs (tremors, ataxia, diarrhea, and other effects) were observed in the pregnant rats and rabbits. Selected studies are presented in Table 13. Gavage - Rat DDVP (97% purity; 0, 0.1, 3.0, or 21.0 mg/kg-day) was given to Sprague-Dawley pregnant rats (25/group) by gavage once daily from gestational days 6 to 15 (Tyl et al., 1991a). Systemic toxicity was observed only in the high dose group. There was a significant (p @ 0.05) reduction in the maternal body weight as the mean maternal weight gain was 66% of control value during the treatment period. Cholinergic signs observed were tremors and excitability. Tremors were observed in the 21.0 mg/kg-day group with the onset within 10-60 minutes after each daily dosing. Other signs of toxicity included prone positioning, hindlimb splay, circling, vocalization, hypoactivity, labored respiration, ear shaking, and coprophagia. Examination of the fetuses showed no significant increases in the incidence of gestational parameters and of individual or pooled external, visceral, skeletal, or total fetal malformations or variations. The incidence (18 fetuses/8 litters) of enlarged lateral ventricles of the cerebrum in the fetuses of the 21.0 mg/kg-day was slightly higher, though not statistically significant, than that (9 fetuses/5 litters) for the control group. The NOELs were 3.0 mg/kg-day for maternal toxicity and greater than 21.0 mg/kg-day for developmental toxicity. This study was considered acceptable to DPR according to FIFRA guidelines. Intraperitoneal - Rat Pregnant Sherman rats (6/group) were given a single dose of DDVP (purity not stated, 15 mg/kg) by intraperitoneal injection on day 11 after insemination (Kimbrough and Gaines, 1968). On day 20 of pregnancy, the fetuses were examined. Of the 41 fetuses examined, omphalocele was noted in 3 fetuses. There were no significant differences in the average weight gain of the dams, average number of fetuses per litter, average number of resorptions, average weight of fetuses, and average weight of placenta. The report noted that a dose of 20 mg/kg DDVP was lethal to pregnant rats. Except for lethality and dam body weights, the report did not include clinical observations. Inhalation - Rat Female rats (Carworth Farm E strain, 9-10/treated group) were exposed to DDVP (>97% purity; at nominal concentrations of 0, 0.25, 1.25, or 6.25 ug/L equivalent to 0, 0.23, 1.15, or 5.75 mg/kg-day) for 23 hours daily by inhalation (Thorpe et al., 1971a). They were treated from day 1 of insemination (pregnancy) to gestation day 20. At the end of the experiment, plasma, erythrocyte, and brain ChE activities of the 1.25 ug/L group were significantly (p

G. DEVELOPMENTAL TOXICITY<br />

Summary: <strong>DDVP</strong>, given by oral or inhalation routes, was not teratogenic in rats, mice, or rabbits.<br />

Cholinergic signs (tremors, ataxia, diarrhea, and other effects) were observed in the pregnant rats and<br />

rabbits. Selected studies are presented in Table 13.<br />

Gavage - Rat<br />

<strong>DDVP</strong> (97% purity; 0, 0.1, 3.0, or 21.0 mg/kg-day) was given to Sprague-Dawley pregnant rats<br />

(25/group) by gavage once daily from gestational days 6 to 15 (Tyl et al., 1991a). Systemic toxicity<br />

was observed only in the high dose group. There was a significant (p @ 0.05) reduction in the<br />

maternal body weight as the mean maternal weight gain was 66% of control value during the<br />

treatment period. Cholinergic signs observed were tremors and excitability. Tremors were observed<br />

in the 21.0 mg/kg-day group with the onset within 10-60 minutes after each daily dosing. Other signs<br />

of toxicity included prone positioning, hindlimb splay, circling, vocalization, hypoactivity, labored<br />

respiration, ear shaking, and coprophagia. Examination of the fetuses showed no significant<br />

increases in the incidence of gestational parameters and of individual or pooled external, visceral,<br />

skeletal, or total fetal malformations or variations. The incidence (18 fetuses/8 litters) of enlarged<br />

lateral ventricles of the cerebrum in the fetuses of the 21.0 mg/kg-day was slightly higher, though not<br />

statistically significant, than that (9 fetuses/5 litters) for the control group. The NOELs were 3.0<br />

mg/kg-day for maternal toxicity and greater than 21.0 mg/kg-day for developmental toxicity. This<br />

study was considered acceptable to DPR according to FIFRA guidelines.<br />

Intraperitoneal - Rat<br />

Pregnant Sherman rats (6/group) were given a single dose of <strong>DDVP</strong> (purity not stated, 15 mg/kg) by<br />

intraperitoneal injection on day 11 after insemination (Kimbrough and Gaines, 1968). On day 20 of<br />

pregnancy, the fetuses were examined. Of the 41 fetuses examined, omphalocele was noted in 3<br />

fetuses. There were no significant differences in the average weight gain of the dams, average<br />

number of fetuses per litter, average number of resorptions, average weight of fetuses, and average<br />

weight of placenta. The report noted that a dose of 20 mg/kg <strong>DDVP</strong> was lethal to pregnant rats.<br />

Except for lethality and dam body weights, the report did not include clinical observations.<br />

Inhalation - Rat<br />

Female rats (Carworth Farm E strain, 9-10/treated group) were exposed to <strong>DDVP</strong> (>97% purity; at<br />

nominal concentrations of 0, 0.25, 1.25, or 6.25 ug/L equivalent to 0, 0.23, 1.15, or 5.75 mg/kg-day)<br />

for 23 hours daily by inhalation (Thorpe et al., 1971a). They were treated from day 1 of insemination<br />

(pregnancy) to gestation day 20. At the end of the experiment, plasma, erythrocyte, and brain ChE<br />

activities of the 1.25 ug/L group were significantly (p

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!